Indian passenger vehicle manufacturers are significantly increasing production and stocking dealerships in anticipation of strong festival season demand, with new launches planned and supply bottlenecks being addressed. However, the industry faces potential moderation in growth during the second half of FY27 due to a high base from last year's post-GST surge, commodity inflation, and elevated inventory levels.
Skoda Auto is strategically navigating the competitive Indian automotive market by prioritising profitable growth, exploring new powertrain options like CNG and a limited diesel return, and gearing up for a locally produced electric SUV, all while expanding its retail footprint.
Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.
Mahindra Group Chairman Anand Mahindra announced the company would adopt an 'attack mode' strategy, accelerating investment, innovation, and execution to capitalise on opportunities arising from prolonged geopolitical and economic uncertainty.
Larsen & Toubro (L&T) is investing Rs 5,000 crore over five years to enter the automotive components sector, focusing on electric vehicle (EV) motors, safety systems, and connected-vehicle technologies, aiming to become a Tier-I auto supplier.
Jaguar Land Rover (JLR) India reported its highest-ever first-quarter retail sales for FY27, with 1,665 vehicles retailed, an 11 per cent year-on-year increase, largely due to sustained demand for premium SUVs and the benefits of the India-UK Free Trade Agreement.
India's passenger vehicle industry is poised for a record-breaking year in 2026, propelled by robust dispatches in the first half of the calendar year and strong demand for utility vehicles, despite facing several economic challenges.
Manipal Health Enterprises is set to launch India's largest healthcare initial public offering (IPO) on July 29, aiming to raise Rs 9,275.22 crore to fund expansion and debt reduction, with the issue closing on July 31.
Dr Reddy's Laboratories reported a 68.7 per cent year-on-year decline in consolidated net profit to Rs 443.5 crore in Q1 FY27, primarily due to the end of its lenalidomide sales agreement, a Rs 240-crore provision for semaglutide API inventory quality issues, and elevated freight costs.
TVS Motor Company reported a significant 56.8 per cent year-on-year increase in net profit to 1,036 crore in Q1FY27, driven by record sales volumes, an improved product mix, and robust demand in both domestic and international markets, with management anticipating continued double-digit industry growth.
The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the taker has had dengue before, eliminating the need for pre-vaccination screening.
BMW Group India says every Re 1 depreciation in the rupee against the euro trims its profit margin by about 1 per cent, prompting the company to consider further price increases.
Nissan Motor India aims to achieve a fourfold increase in domestic sales, targeting 100,000 units annually, and export another 100,000 vehicles from its Chennai plant by financial year 2027-28 (FY28), marking a significant revival of its presence in the Indian passenger vehicle market.
Tata Motors is set to acquire Italy's Iveco Group, a strategic move aimed at propelling the Indian automaker into the top four global commercial vehicle (CV) manufacturers, with projected annual revenues of $35 billion-$40 billion within five years.
Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios.
Health experts warn that rising temperatures could create a growing burden of silent and cumulative health stress across the population.
Indian liquor brands are increasingly focusing on Hindi heartland states like Uttar Pradesh, Rajasthan, and Haryana as the next major growth engine for premiumisation, driven by expanding luxury portfolios, craft spirit launches, and upgraded retail experiences, as state governments embrace reforms.
The luxury carmaker plans to drive growth through local assembly of the MINI Countryman, expansion into 10 new cities and a broader product portfolio.
Titan will continue investments, even as it notes it is too early to assess how customer sentiment and store footfalls will be impacted by the Prime Minister's appeal to reduce gold consumption and the recent hike in import duty.
Sun Pharmaceutical Industries reported strong consolidated numbers for Q4 FY26, with net profit rising 26 per cent year-on-year to 2,714 crore, despite continued weakness in its US generics business. Growth in innovative medicines and increased R&D investments are helping to offset these pressures.
